Report Detail

Pharma & Healthcare COVID-19 Impact on Global Pet Pharmaceuticals, Market Insights and Forecast to 2026

  • RnM4076663
  • |
  • 24 June, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Pet Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Pet Pharmaceuticals market is segmented into
Pill
Injection
Spray
Ointment
Others

Segment by Application, the Pet Pharmaceuticals market is segmented into
Treatment
Prevention

Regional and Country-level Analysis
The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck Animal Health
Merial
Elanco
Bayer
Boehringer Ingolheim
Novartis
Virbac Group
Ceva Sante Animale
Vétoquinol S.A.


1 Study Coverage

  • 1.1 Pet Pharmaceuticals Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pet Pharmaceuticals Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type
    • 1.4.2 Pill
    • 1.4.3 Injection
    • 1.4.4 Spray
    • 1.4.5 Ointment
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Pet Pharmaceuticals Market Size Growth Rate by Application
    • 1.5.2 Treatment
    • 1.5.3 Prevention
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pet Pharmaceuticals Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pet Pharmaceuticals Industry
      • 1.6.1.1 Pet Pharmaceuticals Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pet Pharmaceuticals Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pet Pharmaceuticals Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Pet Pharmaceuticals Market Size Estimates and Forecasts
    • 2.1.1 Global Pet Pharmaceuticals Revenue 2015-2026
    • 2.1.2 Global Pet Pharmaceuticals Sales 2015-2026
  • 2.2 Pet Pharmaceuticals Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Pet Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pet Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pet Pharmaceuticals Competitor Landscape by Players

  • 3.1 Pet Pharmaceuticals Sales by Manufacturers
    • 3.1.1 Pet Pharmaceuticals Sales by Manufacturers (2015-2020)
    • 3.1.2 Pet Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pet Pharmaceuticals Revenue by Manufacturers
    • 3.2.1 Pet Pharmaceuticals Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2019
    • 3.2.5 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pet Pharmaceuticals Price by Manufacturers
  • 3.4 Pet Pharmaceuticals Manufacturing Base Distribution, Product Types
    • 3.4.1 Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pet Pharmaceuticals Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Pet Pharmaceuticals Market Size by Type (2015-2020)
    • 4.1.1 Global Pet Pharmaceuticals Sales by Type (2015-2020)
    • 4.1.2 Global Pet Pharmaceuticals Revenue by Type (2015-2020)
    • 4.1.3 Pet Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pet Pharmaceuticals Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pet Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pet Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Pet Pharmaceuticals Market Size by Application (2015-2020)
    • 5.1.1 Global Pet Pharmaceuticals Sales by Application (2015-2020)
    • 5.1.2 Global Pet Pharmaceuticals Revenue by Application (2015-2020)
    • 5.1.3 Pet Pharmaceuticals Price by Application (2015-2020)
  • 5.2 Pet Pharmaceuticals Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pet Pharmaceuticals Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pet Pharmaceuticals by Country
    • 6.1.1 North America Pet Pharmaceuticals Sales by Country
    • 6.1.2 North America Pet Pharmaceuticals Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pet Pharmaceuticals Market Facts & Figures by Type
  • 6.3 North America Pet Pharmaceuticals Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pet Pharmaceuticals by Country
    • 7.1.1 Europe Pet Pharmaceuticals Sales by Country
    • 7.1.2 Europe Pet Pharmaceuticals Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pet Pharmaceuticals Market Facts & Figures by Type
  • 7.3 Europe Pet Pharmaceuticals Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pet Pharmaceuticals by Region
    • 8.1.1 Asia Pacific Pet Pharmaceuticals Sales by Region
    • 8.1.2 Asia Pacific Pet Pharmaceuticals Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Type
  • 8.3 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pet Pharmaceuticals by Country
    • 9.1.1 Latin America Pet Pharmaceuticals Sales by Country
    • 9.1.2 Latin America Pet Pharmaceuticals Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pet Pharmaceuticals Market Facts & Figures by Type
  • 9.3 Central & South America Pet Pharmaceuticals Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pet Pharmaceuticals by Country
    • 10.1.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
    • 10.1.2 Middle East and Africa Pet Pharmaceuticals Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Corporation Information
    • 11.1.2 Zoetis Description, Business Overview and Total Revenue
    • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Zoetis Pet Pharmaceuticals Products Offered
    • 11.1.5 Zoetis Recent Development
  • 11.2 Merck Animal Health
    • 11.2.1 Merck Animal Health Corporation Information
    • 11.2.2 Merck Animal Health Description, Business Overview and Total Revenue
    • 11.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
    • 11.2.5 Merck Animal Health Recent Development
  • 11.3 Merial
    • 11.3.1 Merial Corporation Information
    • 11.3.2 Merial Description, Business Overview and Total Revenue
    • 11.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merial Pet Pharmaceuticals Products Offered
    • 11.3.5 Merial Recent Development
  • 11.4 Elanco
    • 11.4.1 Elanco Corporation Information
    • 11.4.2 Elanco Description, Business Overview and Total Revenue
    • 11.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Elanco Pet Pharmaceuticals Products Offered
    • 11.4.5 Elanco Recent Development
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Description, Business Overview and Total Revenue
    • 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bayer Pet Pharmaceuticals Products Offered
    • 11.5.5 Bayer Recent Development
  • 11.6 Boehringer Ingolheim
    • 11.6.1 Boehringer Ingolheim Corporation Information
    • 11.6.2 Boehringer Ingolheim Description, Business Overview and Total Revenue
    • 11.6.3 Boehringer Ingolheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
    • 11.6.5 Boehringer Ingolheim Recent Development
  • 11.7 Novartis
    • 11.7.1 Novartis Corporation Information
    • 11.7.2 Novartis Description, Business Overview and Total Revenue
    • 11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novartis Pet Pharmaceuticals Products Offered
    • 11.7.5 Novartis Recent Development
  • 11.8 Virbac Group
    • 11.8.1 Virbac Group Corporation Information
    • 11.8.2 Virbac Group Description, Business Overview and Total Revenue
    • 11.8.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Virbac Group Pet Pharmaceuticals Products Offered
    • 11.8.5 Virbac Group Recent Development
  • 11.9 Ceva Sante Animale
    • 11.9.1 Ceva Sante Animale Corporation Information
    • 11.9.2 Ceva Sante Animale Description, Business Overview and Total Revenue
    • 11.9.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
    • 11.9.5 Ceva Sante Animale Recent Development
  • 11.10 Vétoquinol S.A.
    • 11.10.1 Vétoquinol S.A. Corporation Information
    • 11.10.2 Vétoquinol S.A. Description, Business Overview and Total Revenue
    • 11.10.3 Vétoquinol S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Vétoquinol S.A. Pet Pharmaceuticals Products Offered
    • 11.10.5 Vétoquinol S.A. Recent Development
  • 11.1 Zoetis
    • 11.1.1 Zoetis Corporation Information
    • 11.1.2 Zoetis Description, Business Overview and Total Revenue
    • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Zoetis Pet Pharmaceuticals Products Offered
    • 11.1.5 Zoetis Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pet Pharmaceuticals Market Estimates and Projections by Region
    • 12.1.1 Global Pet Pharmaceuticals Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pet Pharmaceuticals Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pet Pharmaceuticals Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pet Pharmaceuticals Sales Forecast (2021-2026)
    • 12.2.2 North America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pet Pharmaceuticals Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pet Pharmaceuticals Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pet Pharmaceuticals Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pet Pharmaceuticals Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pet Pharmaceuticals Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pet Pharmaceuticals Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pet Pharmaceuticals Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pet Pharmaceuticals Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pet Pharmaceuticals Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pet Pharmaceuticals Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pet Pharmaceuticals Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pet Pharmaceuticals Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pet Pharmaceuticals Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Pet Pharmaceuticals. Industry analysis & Market Report on COVID-19 Impact on Global Pet Pharmaceuticals is a syndicated market report, published as COVID-19 Impact on Global Pet Pharmaceuticals, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pet Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,190.20
    4,785.30
    6,380.40
    3,786.90
    5,680.35
    7,573.80
    606,372.00
    909,558.00
    1,212,744.00
    337,896.00
    506,844.00
    675,792.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report